FDA Adds Boxed Warning to Iron Replacement Injection
(MedPage Today) -- The FDA approved a label change for ferric carboxymaltose injection (Injectafer) that adds a boxed warning for the risk of symptomatic hypophosphatemia.
The agency recommends monitoring of phosphate levels in patients at risk...
Read more »